Meanings of metastatic rcc in English

Conclusions: A range of potent drugs are available to patients with metastatic RCC.

The incidence of RCC is increasing and bone metastatic RCC merits greater focus.

Materials and methods: Whole blood was collected from 55 patients with metastatic RCC.

Study design: Retrospective review of patients diagnosed with metastatic RCC to the head and neck.

Recently, we reported that S-1 was active and well tolerated for the treatment of cytokine-refractory metastatic RCC.

Further studies will be required to assess the overall activity of LEN in patients with metastatic RCC.

We evaluate a marker that has recently been incorporated in clinical practice, PAX-8, in primary and metastatic RCCs.

We evaluated the efficacy and toxicity of a modified dose-schedule of this doublet in patients with metastatic RCC.

Conclusions: CfDNA sequencing enables straightforward characterization of the somatic RCC genome in a minority of patients with metastatic RCC.

We report here two pediatric patients with recurrent metastatic RCC whose tumors expressed MET and were treated with cabozantinib.

Conclusion: OS was similar between axitinib and sorafenib in treatment-naive patients with metastatic RCC, and no new safety signals emerged.

Conclusions: Metastatic RCC to the head and neck is rare but can have serious consequences if not recognized before biopsy.

Conclusion: FDG-PET is not a sensitive imaging modality for the evaluation of metastatic RCC and may not adequately characterize small metastatic lesions.

The advent of immunomodulation through checkpoint inhibition as first line therapy for metastatic RCC represents an exciting horizon for adjuvant and neoadjuvant strategies.

Wedge resections of the lung showed multiple foci of metastatic RCC and extensive involvement of the muscular pulmonary arteries by trisacryl gelatin microspheres.

Methods: Data were collected on all patients identified by the BC Cancer Registry with metastatic RCC who were treated with IFN or sunitinib.